相关实验视频

Updated: Jun 15, 2025

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

准髓质细胞免疫代谢,以改善目前的非小细胞肺癌疗法

Marah C Runtsch¹, Stefano Angiari², Julia Kargl³

¹Division of Pharmacology, Otto Loewi Research Institute, Medical University of Graz, Neue Stiftingtalstraße 6, Graz 8010, Austria; Clinical Division of Oncology, Department of Internal Medicine, Medical University of Graz, Graz, Austria.

Pharmacology & therapeutics

|June 6, 2025

概括

在非小细胞肺癌 (NSCLC) 中准髓质细胞代谢提供了新的治疗策略. 重编程与瘤相关的髓状细胞,如巨细胞和中性粒细胞,可以将它们转移到抗瘤状态,以改善NSCLC治疗.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
代谢过程中的代谢.

背景情况:

尽管免疫疗法的进展,非小细胞肺癌 (NSCLC) 仍然是癌症死亡的主要原因.
肺瘤微环境 (TME) 含有髓状细胞 (巨细胞,中性粒细胞),通过炎症和代谢重编程影响瘤的进展.
目前的治疗方法经常失败,需要新的治疗方法,针对复杂的NSCLC TME.

研究的目的:

审查目前对NSCLC中瘤相关髓状细胞代谢的理解.
为了识别NSCLC治疗的髓状细胞内的潜在代谢标.
探索髓质细胞代谢在重新编程前瘤功能到抗瘤状态中的作用.

主要方法:

关于NSCLC TME中髓状细胞代谢研究的文献综述.
分析TME中的细胞因子和代谢物如何诱导髓状细胞中的代谢重编程.
特定的代谢途径的识别,容易受到药理学操纵.

主要成果:

骨髓细胞代谢显著影响瘤生长和NSCLC中的免疫反应.
可以针对巨细胞和中性粒细胞中的特定代谢途径来改变它们的功能.
将这些细胞从支持瘤转变为抗瘤表型的重编程是一种有前途的治疗途径.

结论:

准髓状细胞代谢是NSCLC治疗的可行策略.
在巨细胞和中性粒细胞中代谢途径的药理学操纵可以增强抗瘤免疫力.
将代谢疗法与目前的治疗方法 (如免疫检查点抑制) 结合起来,可能会改善患者的治疗结果.

关键词:

免疫代谢过程中的免疫代谢.免疫治疗是一种免疫疗法.肺癌是一种肺癌.巨细胞是一个巨细胞.骨髓状细胞是什么? 骨髓状细胞是什么?在NSCLCLC中,我们可以看到.作为一个中性粒细胞.

更多相关视频

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

Experimental Metastasis and CTL Adoptive Transfer Immunotherapy Mouse Model

Experimental Metastasis and CTL Adoptive Transfer Immunotherapy Mouse Model

Published on: November 26, 2010

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...